Grand Pharmaceutical Group Ltd
HKEX:512
Balance Sheet
Balance Sheet Decomposition
Grand Pharmaceutical Group Ltd
Grand Pharmaceutical Group Ltd
Balance Sheet
Grand Pharmaceutical Group Ltd
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
91
|
70
|
44
|
56
|
48
|
59
|
67
|
38
|
60
|
307
|
343
|
305
|
250
|
460
|
654
|
484
|
641
|
912
|
1 059
|
1 837
|
1 753
|
1 444
|
1 340
|
1 341
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
38
|
60
|
307
|
343
|
305
|
250
|
460
|
654
|
484
|
641
|
912
|
1 059
|
1 837
|
1 753
|
1 444
|
1 340
|
1 341
|
|
| Cash Equivalents |
91
|
70
|
44
|
56
|
48
|
59
|
67
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
39
|
41
|
50
|
35
|
8
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
50
|
1
|
11
|
18
|
46
|
72
|
521
|
1 113
|
1 039
|
773
|
1 438
|
|
| Total Receivables |
22
|
17
|
17
|
8
|
8
|
8
|
8
|
65
|
86
|
246
|
349
|
458
|
926
|
1 005
|
1 082
|
1 310
|
1 348
|
1 362
|
1 555
|
1 716
|
2 149
|
2 207
|
2 686
|
3 285
|
|
| Accounts Receivables |
22
|
17
|
17
|
8
|
8
|
6
|
10
|
58
|
77
|
140
|
197
|
209
|
322
|
350
|
466
|
697
|
908
|
929
|
898
|
815
|
968
|
1 094
|
958
|
1 157
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
7
|
9
|
106
|
152
|
249
|
604
|
656
|
617
|
613
|
440
|
433
|
657
|
901
|
1 182
|
1 113
|
1 728
|
2 128
|
|
| Inventory |
11
|
8
|
5
|
4
|
4
|
4
|
8
|
64
|
55
|
216
|
319
|
442
|
562
|
517
|
622
|
636
|
763
|
770
|
814
|
955
|
1 117
|
1 340
|
1 389
|
1 371
|
|
| Other Current Assets |
14
|
1
|
0
|
0
|
0
|
14
|
0
|
10
|
6
|
59
|
76
|
34
|
134
|
101
|
47
|
39
|
178
|
339
|
316
|
290
|
646
|
857
|
829
|
591
|
|
| Total Current Assets |
176
|
137
|
116
|
103
|
68
|
96
|
84
|
177
|
207
|
829
|
1 087
|
1 240
|
1 872
|
2 133
|
2 406
|
2 481
|
2 947
|
3 429
|
3 816
|
5 319
|
6 779
|
6 887
|
7 016
|
8 026
|
|
| PP&E Net |
192
|
197
|
154
|
89
|
33
|
33
|
35
|
132
|
138
|
451
|
726
|
1 423
|
2 109
|
2 291
|
2 543
|
2 644
|
2 892
|
2 876
|
3 264
|
3 410
|
3 802
|
3 942
|
3 986
|
4 266
|
|
| PP&E Gross |
192
|
197
|
154
|
89
|
33
|
33
|
35
|
132
|
138
|
451
|
726
|
1 423
|
2 109
|
2 291
|
2 543
|
2 644
|
2 892
|
2 876
|
3 264
|
3 410
|
3 802
|
3 942
|
3 986
|
4 266
|
|
| Accumulated Depreciation |
221
|
204
|
177
|
219
|
131
|
136
|
145
|
6
|
17
|
47
|
87
|
150
|
161
|
241
|
401
|
542
|
794
|
932
|
1 366
|
1 641
|
1 910
|
2 057
|
2 264
|
2 554
|
|
| Intangible Assets |
0
|
55
|
130
|
71
|
13
|
12
|
0
|
2
|
1
|
1
|
1
|
0
|
83
|
68
|
651
|
796
|
876
|
816
|
795
|
882
|
1 010
|
1 398
|
1 657
|
2 083
|
|
| Goodwill |
0
|
0
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
55
|
72
|
97
|
125
|
125
|
381
|
481
|
512
|
488
|
480
|
506
|
597
|
644
|
589
|
1 300
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
17
|
37
|
20
|
0
|
14
|
0
|
0
|
0
|
0
|
114
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
7
|
5
|
14
|
8
|
76
|
75
|
75
|
58
|
66
|
40
|
60
|
64
|
50
|
46
|
322
|
371
|
439
|
5 481
|
5 341
|
6 437
|
8 380
|
8 447
|
8 398
|
8 213
|
|
| Other Long-Term Assets |
2
|
0
|
0
|
0
|
4
|
4
|
4
|
201
|
196
|
311
|
468
|
492
|
307
|
305
|
316
|
368
|
397
|
407
|
117
|
317
|
491
|
1 054
|
870
|
1 104
|
|
| Other Assets |
0
|
0
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
55
|
72
|
97
|
125
|
125
|
381
|
481
|
512
|
488
|
480
|
506
|
597
|
644
|
589
|
1 300
|
|
| Total Assets |
377
N/A
|
394
+5%
|
414
+5%
|
270
-35%
|
197
-27%
|
220
+12%
|
199
-10%
|
570
+186%
|
609
+7%
|
1 687
+177%
|
2 431
+44%
|
3 354
+38%
|
4 565
+36%
|
4 991
+9%
|
6 633
+33%
|
7 142
+8%
|
8 063
+13%
|
13 497
+67%
|
13 813
+2%
|
16 984
+23%
|
21 057
+24%
|
22 371
+6%
|
22 515
+1%
|
24 991
+11%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
64
|
44
|
40
|
33
|
49
|
3
|
3
|
79
|
63
|
136
|
145
|
305
|
708
|
655
|
653
|
702
|
628
|
1 056
|
834
|
662
|
734
|
873
|
1 330
|
1 217
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
51
|
50
|
64
|
75
|
159
|
156
|
310
|
598
|
466
|
529
|
662
|
942
|
1 287
|
1 192
|
1 477
|
2 137
|
1 615
|
1 499
|
1 711
|
|
| Short-Term Debt |
0
|
1
|
8
|
25
|
10
|
22
|
14
|
0
|
0
|
0
|
0
|
0
|
0
|
12
|
0
|
0
|
0
|
285
|
0
|
60
|
7
|
2
|
2
|
2
|
|
| Current Portion of Long-Term Debt |
52
|
49
|
52
|
96
|
43
|
54
|
92
|
77
|
118
|
307
|
695
|
1 306
|
1 268
|
1 089
|
2 006
|
1 712
|
2 222
|
2 021
|
990
|
1 575
|
2 122
|
3 253
|
2 353
|
3 146
|
|
| Other Current Liabilities |
60
|
60
|
60
|
64
|
70
|
0
|
0
|
2
|
8
|
35
|
35
|
36
|
40
|
50
|
61
|
81
|
215
|
318
|
573
|
529
|
565
|
711
|
547
|
497
|
|
| Total Current Liabilities |
176
|
154
|
161
|
218
|
172
|
131
|
159
|
222
|
264
|
637
|
1 031
|
1 957
|
2 614
|
2 273
|
3 249
|
3 157
|
4 007
|
4 967
|
3 590
|
4 303
|
5 566
|
6 455
|
5 731
|
6 573
|
|
| Long-Term Debt |
0
|
2
|
78
|
0
|
0
|
0
|
0
|
195
|
150
|
40
|
37
|
116
|
404
|
668
|
1 179
|
1 211
|
769
|
320
|
1 075
|
814
|
1 523
|
1 222
|
1 052
|
1 297
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
2
|
2
|
0
|
45
|
43
|
68
|
83
|
81
|
50
|
59
|
144
|
189
|
196
|
179
|
172
|
182
|
198
|
220
|
222
|
300
|
|
| Minority Interest |
13
|
29
|
31
|
13
|
3
|
3
|
1
|
84
|
96
|
279
|
331
|
126
|
214
|
195
|
245
|
274
|
226
|
244
|
136
|
105
|
50
|
68
|
113
|
52
|
|
| Other Liabilities |
0
|
23
|
1
|
0
|
0
|
75
|
81
|
20
|
22
|
96
|
311
|
321
|
406
|
683
|
657
|
609
|
632
|
596
|
467
|
342
|
327
|
265
|
240
|
295
|
|
| Total Liabilities |
189
N/A
|
208
+10%
|
271
+30%
|
230
-15%
|
178
-23%
|
211
+19%
|
242
+15%
|
565
+133%
|
576
+2%
|
1 119
+94%
|
1 792
+60%
|
2 601
+45%
|
3 688
+42%
|
3 877
+5%
|
5 474
+41%
|
5 440
-1%
|
5 829
+7%
|
6 306
+8%
|
5 438
-14%
|
5 745
+6%
|
7 664
+33%
|
8 231
+7%
|
7 358
-11%
|
8 518
+16%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
82
|
98
|
138
|
4
|
11
|
11
|
11
|
11
|
11
|
19
|
19
|
20
|
20
|
20
|
20
|
22
|
22
|
31
|
34
|
35
|
35
|
35
|
35
|
35
|
|
| Retained Earnings |
31
|
62
|
150
|
81
|
17
|
27
|
79
|
100
|
72
|
256
|
311
|
402
|
502
|
677
|
787
|
1 044
|
1 469
|
2 183
|
3 037
|
4 506
|
6 535
|
8 224
|
9 607
|
11 190
|
|
| Additional Paid In Capital |
208
|
220
|
224
|
25
|
94
|
94
|
94
|
94
|
94
|
269
|
269
|
282
|
282
|
282
|
282
|
661
|
661
|
5 052
|
5 511
|
6 523
|
6 523
|
6 523
|
6 523
|
6 523
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
12
|
3
|
99
|
279
|
341
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
144
|
187
|
269
|
269
|
|
| Other Equity |
70
|
70
|
70
|
70
|
69
|
69
|
69
|
0
|
0
|
18
|
37
|
46
|
74
|
135
|
71
|
24
|
82
|
76
|
208
|
163
|
440
|
355
|
460
|
666
|
|
| Total Equity |
189
N/A
|
186
-2%
|
142
-24%
|
40
-72%
|
19
-53%
|
9
-53%
|
43
N/A
|
5
N/A
|
33
+560%
|
568
+1 621%
|
639
+13%
|
753
+18%
|
877
+16%
|
1 113
+27%
|
1 160
+4%
|
1 702
+47%
|
2 234
+31%
|
7 191
+222%
|
8 375
+16%
|
11 240
+34%
|
13 393
+19%
|
14 140
+6%
|
15 158
+7%
|
16 473
+9%
|
|
| Total Liabilities & Equity |
377
N/A
|
394
+5%
|
414
+5%
|
270
-35%
|
197
-27%
|
220
+12%
|
199
-10%
|
570
+186%
|
609
+7%
|
1 687
+177%
|
2 431
+44%
|
3 354
+38%
|
4 565
+36%
|
4 991
+9%
|
6 633
+33%
|
7 142
+8%
|
8 063
+13%
|
13 497
+67%
|
13 813
+2%
|
16 984
+23%
|
21 057
+24%
|
22 371
+6%
|
22 515
+1%
|
24 991
+11%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
43
|
51
|
72
|
374
|
1 121
|
1 121
|
1 121
|
1 121
|
1 121
|
1 931
|
1 931
|
1 973
|
1 973
|
1 973
|
1 973
|
2 249
|
2 249
|
3 135
|
3 378
|
3 550
|
3 550
|
3 519
|
3 502
|
3 502
|
|